Acción DALS DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas DA32 Life Science Tech Acquisition Corp.

Acciones

DALS

US23312M1062

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
DA32 Life Science Tech Acquisition Corp.(NasdaqCM:DALS) dropped from NASDAQ Composite Index
DA32 Life Science Tech Acquisition to Redeem All Shares
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
DA32 Life Science Tech Acquisition Corp. Auditor Raises 'Going Concern' Doubt
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Eight Months Ended December 31, 2021
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 23-JAN-2022.
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Other Events (form 8-K)
DA32 Life Science Tech Acquisition Corp. : Sponsored by Deerfield, ARCH Venture Partners and Section 32, Announces Closing of $200 Million Initial Public Offering
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)
DA32 Life Science Tech Acquisition Corp. Announces Executive Changes
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción DALS
  4. Noticias DA32 Life Science Tech Acquisition Corp.
  5. Otros idiomas